Kenvue's IPO Offers Glimmer Of Hope During Bleak Times
Johnson & Johnson consumer-health spinoff Kenvue Inc.'s recent $3.8 billion initial public offering, the largest new listing since 2021, breathed fresh life into a moribund IPO market that experts say will...To view the full article, register now.
Already a subscriber? Click here to view full article